166
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Positive association of MMP 14 gene polymorphism with vulnerable carotid plaque formation in a Han Chinese population

, , , , , , , , & show all
Pages 248-253 | Received 31 May 2013, Accepted 29 Dec 2013, Published online: 28 Jan 2014

References

  • Lenglet S, Thomas A, Chaurand P, Galan K, Mach F, Montecucco F. Molecular imaging of matrix metalloproteinases in atherosclerotic plaques. Thromb Haemost 2012;107:409–16.
  • Wang F, Jin XP, Zhu M, Lin XF, Hu XF, Wang WF, Han Z, Huang LZ. Genotype association of C(-735) T polymorphism of the MMP-2 gene with the risk of carotid atherosclerosis-vulnerable plaque in the Han Chinese population. Vasc Med 2011;16:13–8.
  • Hu XF, Jin XP, Hu PY, Zhu M, Wang F, Lin XF, Li WL, Ni H, Yang LH. Association of a functional polymorphism in the MMP7 gene promoter with susceptibility to vulnerable carotid plaque in a Han Chinese population. Clin Chem Lab Med 2011;49:1735–41.
  • Chun TH, Inoue M, Morisaki H, Yamanaka I, Miyamoto Y, Okamura T, Sato-Kusubata K, Weiss SJ. Genetic link between obesity and MMP14-dependent adipogenic collagen turnover. Diabetes 2010;59:2484–94.
  • Schneider F, Sukhova GK, Aikawa M, Canner J, Gerdes N, Tang SM, Shi GP, Apte SS, Libby P. Matrix-metalloproteinase-14 deficiency in bone-marrow-derived cells promotes collagen accumulation in mouse atherosclerotic plaques. Circulation 2008;117:931–9.
  • Hwang IK, Park SM, Kim SY, Lee ST. A proteomic approach to identify substrates of matrix metalloproteinase-14 in human plasma. Biochim Biophys Acta 2004;1702:79–87.
  • Tailleux A, Fruchart JC. HDL heterogeneity and atherosclerosis. Crit Rev Clin Lab Sci 1996;33:163–201.
  • Bocksch L, Stephens T, Lucas A, Singh B. Apolipoprotein E: possible therapeutic target for atherosclerosis. Curr Drug Targets Cardiovasc Haematol Disord 2001;1:93–106.
  • Kim SY, Park SM, Lee ST. Apolipoprotein C-II is a novel substrate for matrix metalloproteinases. Biochem Biophys Res Commun 2006;339:47–54.
  • Mead JR, Irvine SA, Ramji DP. Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med (Berl) 2002;80:753–69.
  • Jenkins GM, Crow MT, Bilato C, Gluzband Y, Ryu WS, Li Z, Stetler-Stevenson W, Nater C, Froehlich JP, Lakatta EG, Cheng L. Increased expression of membrane-type matrix metalloproteinase and preferential localization of matrix metalloproteinase-2 to the neointima of balloon-injured rat carotid arteries. Circulation 1998;97:82–90.
  • Deschamps AM, Yarbrough WM, Squires CE, Allen RA, McClister DM, Dowdy KB, McLean JE, Mingoia JT, Sample JA, Mukherjee R, Spinale FG. Trafficking of the membrane type-1 matrix metalloproteinase in ischemia and reperfusion: relation to interstitial membrane type-1 matrix metalloproteinase activity. Circulation 2005;111:1166–74.
  • Rajavashisth TB, Xu XP, Jovinge S, Meisel S, Xu XO, Chai NN, Fishbein MC, Kaul S, Cercek B, Sharifi B, Shah PK. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation 1999;99:3103–9.
  • Johnson JL. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability. Expert Rev Cardiovasc Ther 2007;5:265–82.
  • Chen TY, Li YC, Liu YF, Tsai CM, Hsieh YH, Lin CW, Yang SF, Weng CJ. Role of MMP14 gene polymorphisms in susceptibility and pathological development to hepatocellular carcinoma. Ann Surg Oncol 2011;18:2348–56.
  • Weng CJ, Chen MK, Lin CW, Chung TT, Yang SF. Single nucleotide polymorphisms and haplotypes of MMP-14 are associated with the risk and pathological development of oral cancer. Ann Surg Oncol 2012; 19(Suppl. 3):S319–27.
  • Society CD. China guideline for Type 2 diabetes in 2010. Chin J Diabetes 2010;20:S1–36.
  • Saitoh W, Sakamoto T, Hegab AE, Nomura A, Ishii Y, Morishima Y, Kai S, Iizuka T, Kiwamoto T, Matsuno Y, Massoud HH, Massoud HM, Hassanein KM, Sekizawa K. MMP14 gene polymorphisms in chronic obstructive pulmonary disease. Int J Mol Med 2006;17: 621–6.
  • Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493–503.
  • Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol 1997;17:1859–67.
  • Spurthi KM, Galimudi RK, Srilatha G, Sahu SK, Nallari P, Hanumanth SR. Influence of gelatinase B polymorphic variants and its serum levels in atherosclerosis. Genet Test Mol Biomarkers 2012;16:850–4.
  • Lin RT, Chen CH, Tsai PC, Ho BL, Juo SH, Lin HF. Sex-specific effect of matrix metalloproteinase-9 functional promoter polymorphism on carotid artery stiffness. Atherosclerosis 2012;223:416–20.
  • Djuric T, Stojkovic L, Zivkovic M, Koncar I, Stankovic A, Djordjevic A, Alavantic D. Matrix metalloproteinase- 1 promoter genotypes and haplotypes are associated with carotid plaque presence. Clin Biochem 2012;45:1353–6.
  • Goncalves I, Moses J, Dias N, Pedro LM, Fernandes EFJ, Nilsson J, Ares MP. Changes related to age and cerebrovascular symptoms in the extracellular matrix of human carotid plaques. Stroke 2003;34:616–22.
  • Hector EE, Robins SP, Mercer DK, Brittenden J, Wainwright CL. Quantitative measurement of mature collagen cross-links in human carotid artery plaques. Atherosclerosis 2010;211:471–4.
  • Chun TH, Hotary KB, Sabeh F, Saltiel AR, Allen ED, Weiss SJ. A pericellular collagenase directs the 3-dimensional development of white adipose tissue. Cell 2006;125: 577–91.
  • Aikawa M, Libby P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc Pathol 2004;13:125–38.
  • Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, Gottesman MM. A ‘silent’ polymorphism in the MDR1 gene changes substrate specificity. Science 2007;315:525–8.
  • van Lammeren GW, Reichmann BL, Moll FL, Bots ML, de Kleijn DP, de Vries JP, Pasterkamp G, de Borst GJ. Atherosclerotic plaque vulnerability as an explanation for the increased risk of stroke in elderly undergoing carotid artery stenting. Stroke 2011;42:2550–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.